TMCnet News
Nanotechnology in Medical Applications: The Global MarketNEW YORK, Oct. 12, 2017 /PRNewswire/ -- The global nanomedical market was valued at $134.4 billion in 2016. This market is projected to grow at a compound annual growth rate (CAGR) of 14.0% from 2017 through 2022 and should reach $293.1 billion by 2022 from $151.9 billion in 2017. Five-year sales forecasts are provided for the national markets including the major therapeutic categories of products involved. Specific product categories quantified include diagnostics, cancer, CNS, anti-infective agents, cardiovasculars and anti- inflammatories. Market Analyses and Forecasts Market figures are based on revenues at the manufacturer level and are projected at the 2017-dollar value without attempting to predict the effect of inflation or deflation. The quantified therapeutic categories forecast include cancer, central nervous system (CNS) diseases, infections and cardiovascular conditions. The country markets analyzed are the U.S., Japan, Germany, France, the U.K., Italy and Spain. Methodology Primary research included interviews with leading individuals in nanomedicine companies and industry associations. Principal sources of published data include company annual reports and SEC filings as well as government and industry publications. Secondary sources consist of literature searches, industry journals and other commercial publications. Data for market estimates and forecasts were pooled from a range of sources, critically assessed by BCC Research. Intended Audience This report is designed to satisfy the information needs of a wide variety of individuals involved in the pharmaceutical marketplace, including company senior management executives seeking to base their strategic decisions on the best available information on market forces and trends. However, it is also aimed at managers and executives in marketing, research, planning and sales departments who need readable, comprehensive and up-to-date background on the marketplace in which they are operating. Information Sources Sources of information included marketing strategists, industry executives, government agencies and regulatory bodies, and surveys of physicians and pharmacists. Company annual reports and SEC filings, journal articles, and data from healthcare institutions were also mined, as well as publications of relevant trade associations. Global Market for Nanomedicals, by Therapeutic Area Anticancers CNS products Anti-infectives Cardiovasculars Anti-inflammatories Others Chapter 2: Summary and Highlights Nanomedicine Market Nano-enabled medical products began appearing on the market over a decade ago, and some have become best-sellers in their therapeutic categories. The principal areas in which nanomedical products have made an impact are cancer, CNS diseases, cardiovascular disease and infection control. The Summary Table gives estimates of the historical and current markets for these nanomedicine areas with a forecast through 2022. The U.S. market is by far the largest in the global nanomedicine market and is set to continue to dominate the world marketplace; however, other national markets are expected to increase their shares over the next five years. Read the full report: https://www.reportlinker.com/p0170502 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. https://www.reportlinker.com __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001 View original content:http://www.prnewswire.com/news-releases/nanotechnology-in-medical-applications-the-global-market-300536152.html SOURCE Reportlinker 
|